Advertisement

Topics

Pharmatech Innovation Signs Strategic Alliance Agreement With Labofine

03:00 EST 6 Mar 2017 | PR Web

PharmaTech INNOVATION Inc., a fully integrated pharmaceutical company offering generic and proprietary drugs formulation and manufacturing, is pleased to announce that it has signed a Strategic Alliance Agreement with Labofine Inc., a fully certified Montreal-based company offering Analytical Testing and other services to the pharmaceutical, nutraceutical and cosmetics industries. Pursuant to the Agreement, PharmaTech INNOVATION and Labofine will work together to advance their respective business interests.

Montreal, QC (PRWEB) March 06, 2017

PharmaTech INNOVATION Inc., a fully integrated pharmaceutical company offering generic and proprietary drugs formulation and manufacturing, is pleased to announce that it has signed a Strategic Alliance Agreement with Labofine Inc., a fully certified Montreal-based company offering Analytical Testing and other services to the pharmaceutical, nutraceutical and cosmetics industries. Pursuant to the Agreement, PharmaTech INNOVATION and Labofine will work together to advance their respective business interests. In addition, Labofine will provide regulatory compliance consulting, logistics and quality control for PharmaTech INNOVATION Operations.

About Labofine Inc.
Labofine Inc. is an analytical services laboratory providing testing and quality control of pharmaceuticals, cosmetics and natural products. Labofine has a Drug Establishment License (DEL) from Health Canada to conduct licensable activities in a building which has been inspected and assessed as being in compliance with the requirements of Good Manufacturing Practices (GMP). All testing activities and other activities of Labofine meet the standards of Good Manufacturing Practice (GMP).
http://www.Labofine.com

About PharmaTech INNOVATION Inc.
PharmaTech INNOVATION is a research driven company and is one of the operative divisions of Smart Medicines GMP Inc. PharmaTech INNOVATION focuses on research and development in pharmaceutical products and services as well as cosmetics, nutrition and medicinal herbs. Their expertise includes regulatory affairs and its toxicological, environmental and nano- and bio-technological considerations. As one of the operative arms of Smart Medicines GMP Inc., PharmaTech INNOVATION will benefit of 25 Million dollars investments to run its R&D Facility in Laval (Qc) over the next 4 years.

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/03/prweb14119525.htm

NEXT ARTICLE

More From BioPortfolio on "Pharmatech Innovation Signs Strategic Alliance Agreement With Labofine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...